Type of myocardial infarction presentation in patients with chronic kidney disease

被引:3
|
作者
Ferrara, L. A. [1 ]
Staiano, L. [1 ]
Di Fronzo, V. [1 ]
Ferrara, F. [1 ]
Sforza, A. [2 ]
Mancusi, C. [2 ]
de Simone, G. [2 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy
[2] Univ Naples Federico II, Hypertens Res Ctr, I-80131 Naples, Italy
关键词
S-T Elevated MI (STEMI); Non S-T Elevated MI (NSTEMI); Chronic kidney disease; TIMI RISK SCORE; ST-ELEVATION; CARDIOVASCULAR MORTALITY; ENDOTHELIAL DYSFUNCTION; EUROPEAN-SOCIETY; CARDIOLOGY;
D O I
10.1016/j.numecd.2014.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: Association of coronary and renal disease has been frequently found in epidemiological studies. Whether ECG-graphic presentation of myocardial infarction [S-T Elevated MI (STEMI) or Non S-T Elevated MI (NSTEMI)] is related to the degree of renal dysfunction is still unclear. Methods and results: We examined 146 patients with acute myocardial infarction, consecutively entering the Coronary Care Unit of our ward. At entry, patients underwent clinical, ECG-graphic and echocardiographic examination, and blood samples were withdrawn for cardiac markers and general biochemistry. GFR was calculated using the CKD-EPI equation. STEMI was found in 71 cases and NSTEMI in 75 cases. Renal functionwas normal in 61 patients (stage 1), mildly impaired (< 90 mL/min/1.73 m(2) and >= 60 mL/min/1.73 m2) in 60 (stage 2) and moderately to severely impaired (GFR < 60 mL/min/1.73 m(2)) in 25 cases (stages 3-4). Patients were, thereafter, clustered into two groups (stages 1-2 and stages 3-4). Compared to stage 1-2 subjects, stages 3-4 patients were older, were more likely to be diabetic and had more frequently previous cardiovascular diseases. The probability of presentation of NSTEMI for stage 3-4 patients was 4-fold greater than for stage 1-2 patients (p = 0.02). Conclusions: These data support the evidence that 1) NSTEMI is associated with more severe kidney dysfunction, likely due to more severe and/or longer lasting exposition to risk factors; 2) cardiac and renal impairment are strongly associated. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [21] Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
    Franczyk-Skora, Beata
    Gluba, Anna
    Banach, Maciej
    Rysz, Jacek
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (06) : 1019 - 1027
  • [22] Presentation and outcomes in patients with acute myocardial injury and type 2 myocardial infarction with prior coronary artery disease
    Taggart, Caelan
    Gard, Anton
    Bularga, Anda
    Wereski, Ryan
    Lindahl, Bertil
    Eggers, Andrew R. Chapman Kai
    Mills, Nicholas L.
    [J]. SCOTTISH MEDICAL JOURNAL, 2023, 68 (02) : NP3 - NP4
  • [23] Chronic Kidney Disease and Dipstick Proteinuria Are Risk Factors for Stent Thrombosis in Patients With Myocardial Infarction
    Lambert, Nathan D.
    Sacrinty, Matthew T.
    Ketch, Terry R.
    Turner, Samuel J.
    Santos, Renato M.
    Daniel, Kurt R.
    Applegate, Robert J.
    Kutcher, Michael A.
    Sane, David C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A319 - A319
  • [24] Comparison of Drug-Eluting Stents in Acute Myocardial Infarction Patients with Chronic Kidney Disease
    Hachinohe, Daisuke
    Jeong, Myung Ho
    Saito, Shigeru
    Kim, Min Chol
    Cho, Kyung Hoon
    Ahmed, Khurshid
    Hwang, Seung Hwan
    Lee, Min Goo
    Sim, Doo Sun
    Park, Keun-Ho
    Kim, Ju Han
    Hong, Young Joon
    Ahn, Youngkeun
    Kang, Jung Chaee
    Kim, Jong Hyun
    Chae, Shung Chull
    Kim, Young Jo
    Hur, Seung Ho
    Seong, In Whan
    Hong, Taek Jong
    Choi, Donghoon
    Cho, Myeong Chan
    Kim, Chong Jin
    Seung, Ki Bae
    Chung, Wook Sung
    Jang, Yang Soo
    Rha, Seung Woon
    Bae, Jang Ho
    Park, Seung Jung
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2012, 27 (04): : 397 - 406
  • [25] Sitagliptin and cardiovascular outcomes in diabetic patients with chronic kidney disease after acute myocardial infarction
    Kawada, Tomoyuki
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 1072 - 1073
  • [26] Impact of Chronic Kidney Disease on Revascularization and Outcomes in Patients with ST-Elevation Myocardial Infarction
    Panchal, Hemang B.
    Zheng, Shimin
    Devani, Kalpit
    White, Christopher J.
    Leinaar, Edward F.
    Mukherjee, Debabrata
    Mamas, Mamas
    Banerjee, Subhash
    Bhatt, Deepak L.
    Jneid, Hani
    Samady, Habib
    Mehran, Roxana
    Gharacholou, Shahyar M.
    Paul, Timir K.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 150 : 15 - 23
  • [27] Effects of chronic kidney disease on platelet response to antiplatelet therapy in acute myocardial infarction patients
    邓捷
    [J]. China Medical Abstracts (Internal Medicine), 2012, 29 (04) : 231 - 231
  • [28] EFFECTS OF CHRONIC KIDNEY DISEASE ON PLATELET RESPONSE TO ANTIPLATELET THERAPY IN ACUTE MYOCARDIAL INFARCTION PATIENTS
    Deng Jie
    Han Yaling
    Wang Xiaozeng
    Zhao Xin
    [J]. HEART, 2013, 99 : A51 - A51
  • [29] Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease
    Abid, Leila
    Charfeddine, Salma
    Kammoun, Samir
    Turki, Mouna
    Ayedi, Fatma
    [J]. JOURNAL OF THE SAUDI HEART ASSOCIATION, 2016, 28 (03) : 144 - 151
  • [30] Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
    Lambert, Nathan D.
    Sacrinty, Matthew T.
    Ketch, Terry R.
    Turner, Samuel J.
    Santos, Renato M.
    Daniel, Kurt R.
    Applegate, Robert J.
    Kutcher, Michael A.
    Sane, David C.
    [J]. AMERICAN HEART JOURNAL, 2009, 157 (04) : 688 - 694